F

Forbion

47 employees

Forbion Capital Partners is a private equity and venture capital firm for making investments in buyouts.

Investor insights

Countries invested in

denmark2
netherlands1

Sectors invested in

Biotechnology80
Health Care57
Medical37
Therapeutics33
Pharmaceutical23
Genetics14
Biopharma14
Health Diagnostics10
Life Science9
Immunotherapy7
Clinical Trials7
Medical Device6
biofluids5
biomarkers5
exosomes and microvesicles5
diagnostic development5
Infectious diseases4
Immuno-Oncology4
Oncology4
Diabetes3

Funding rounds participated in

$31M sweet spot round size

Most of their 109 investments are in rounds between $18M and $54M

Investor type

Private Equity Firm
Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Health care
Biotechnology
Medical devices
Health Care
Therapeutics
Developing novel drugs
life sciences
Bioscience
Venture Capital
Investment

Date founded

2006

Investments made

M

Mariana Oncology raised $175M on September 7, 2023

Investors: Surveyor Capital, Nextech Invest, Atlas Ventures, RA Capital Management, L.P. and Forbion

d

dualyx raised $44M on May 15, 2023

Investors: KU Leuven Innovation & Entrepreneurship, V-Bio Ventures, Andera Partners, High-Tech Gründerfonds, BGV (BioGeneration Ventures), VIB and Forbion

C

Complement Therapeutics raised $79M on April 17, 2023

Investors: Gimv, Hadean Ventures, PANAKES, BGV (BioGeneration Ventures), Cambridge Innovation Capital plc, Seroba-Kernel Ltd (Ireland) and Forbion

N

Noema Pharma raised $110M on March 7, 2023

Investors: UPMC Enterprises, Polaris Partners, Sofinnova Partners, The Invus Group, JEITO, Gilde Healthcare and Forbion

N

NewAmsterdam Pharma raised $235M on November 23, 2022

Investors: Life Sciences Partners (LSP), Frazier Healthcare Partners, Medicxi, RA Capital Management, L.P., GMT Capital and Forbion

C

CatalYm GmbH raised $51M on November 22, 2022

Investors: Brandon Capital Partners, coparion, JEITO, Vesalius Biocapital, BGV (BioGeneration Ventures), Bayern Kapital GmbH and Forbion

I

Inversago Pharma Inc raised $69M on October 17, 2022

Investors: adMare BioInnovations, Genesys Capital, JDRF T1D Fund and Forbion

V

VectivBio AG raised $125M on October 13, 2022

Investors: TCG X, Surveyor Capital, OrbiMed Advisors, Eventide Asset Management, Marshall Wace, Vivo Capital, Driehaus Capital Management LLC and Forbion

P

Pheon Therapeutics raised $68M on September 28, 2022

Investors: Research Corporation Technologies, Inc., Atlas Venture, Brandon Capital Partners and Forbion

F

F2G raised $70M on August 4, 2022

Investors: Sofinnova Partners and Forbion

FAQ